期刊文献+

肿瘤翻译调控蛋白在人乳腺癌组织中的表达及临床意义 被引量:6

Expression of translationally controlled tumor protein in human breast cancer and its clinical significance
下载PDF
导出
摘要 目的探讨人肿瘤翻译控制蛋白(TCTP)在浸润性乳腺癌组织中的表达情况并分析TCTP表达与临床病理特征的关系。方法采用链霉素-生物素过氧化物酶免疫组织化学法检测94例浸润性乳腺癌及正常乳腺组织中TCTP蛋白的表达水平。结果浸润性乳腺癌组织中TCTP蛋白的阳性表达率显著高于癌旁正常乳腺组(P<0.001),TCTP的表达水平与乳腺癌肿瘤直径、临床分期、组织分级以及淋巴结转移情况密切相关(P<0.05),而与乳腺癌患者年龄、不同组织学类型之间的关系无统计学意义(P>0.05)。乳腺癌肿瘤直径愈大、临床分期愈高,乳腺癌组织中TCTP的表达阳性率也愈高;且有淋巴结转移者的TCTP阳性表达率明显高于无淋巴结转移者(P=0.003)。生存期分析显示,TCTP表达阳性的患者生存时间(52.0±3.7)月明显短于阴性表达的患者(88.6±3.6)月,(P<0.001)。结论 TCTP的异常表达参与了乳腺癌的演进过程,并且是乳腺癌患者预后不良的一个独立指标。 Objective To investigate the expression of translationally controlled tumor protein(TCTP) in human breast cancer tissues and its clinical significances.Methods The expression of TCTP in 94 human breast cancer and the corresponding adjacent normal mammary tissues were detected using immunohistochemistry.Results The expression rate of TCTP was 64.89% in human breast cancer tissues,significantly higher than that in normal benign mammary tissues(39.36%,P〈0.001).TCTP overexpression was positively correlated to the tumor size,clinical stage,lymph node metastasis and histological grade of breast cancer(P〈0.05).Patients with positive TCTP expression had a significantly shorter mean survival time than those with negative expression(P〈0.001).Conclusion TCTP may play an important role in the tumorigenesis and development of breast cancer,and can be an important prognostic factor for this malignancy.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2011年第9期1560-1563,共4页 Journal of Southern Medical University
基金 吉林省自然科学基金(201015155) 吉林大学基本科研业务费资助课题(421030170428)
关键词 乳腺癌 肿瘤翻译控制蛋白 breast cancer translationally controlled tumor protein
  • 相关文献

参考文献8

  • 1Bommer UA, Heng C, Perrin A, et al. Roles of the translationally controlled turnout protein (TCTP) and the double-stranded RNA-dependent protein kinase, PKR, in cellular stress responses [J]. Oncogene, 2010, 29(5): 763-73.
  • 2Masunaga R, Kohno H, Dhar DK, et al. Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients[J]. Clin Cancer Res, 2000, 6 (10): 4064-8.
  • 3Burgess A, Labbe JC, Vigncron S, et al. Chfr interacts and colocalizes with TCTP to the mitotic spindle[J]. Oncogene, 2008, 27 (42): 5554-66.
  • 4Yang Y, Yang F, Xiong Z, et al. An N-terminal region of translationally controlled tumor protein is required for its antiapoptotic activity[J]. Oncogene, 2005, 24(30): 4778-88.
  • 5Lee JH, Rho SB, Park SY, et al. Interaction between fortilin and transforming growth factor-beta stimulated clone-22 (TSC-22) prevents apoptosis via the destabilization of TSC-22 [J]. FEBS Lett, 2008, 582(8): 1210-8.
  • 6Wanachottrakul N, Chotigeat W, Kedjarune-Leggat U. Transla- tionally controlled tumor protein against apoptosis from 2-hydroxy-ethyl methacrylate in human dental pulp cells [J]. J Mater Sci Mater Med, 2011, 22(6): 1479-87.
  • 7Kim HY, Kim S, Youn H, et al. The cell penetrating ability of the proapoptotic peptide, KLAKLAKKLAKLAK fused to the N-terminal protein transduction domain of translationally controlled tumor protein, MIIYRDLISH[J]. Biomaterials, 2011, 32 (22): 5262-8.
  • 8Baziie F, Pascal A, Areal I, et al. Complex relationship between TCTP, microtubules and actin microfilaments regulates cell shape in normal and cancer cells[J]. Carcinogenesis, 2009, 30(4): 555-65.

同被引文献46

  • 1狄根红,亓发芝,吴炅,陆劲松,沈坤炜,沈镇宙,邵志敏.乳腺癌改良根治术后一期乳房再造[J].复旦学报(医学版),2004,31(4):434-435. 被引量:35
  • 2刘卫红,孟秀香,刘丹丹,单路娟,赵心宇.反义Bmi-1对Jurkat细胞的抑制作用[J].中华血液学杂志,2005,26(9):554-556. 被引量:19
  • 3牛兆河,栾杰,穆大力,刘晨,王凌宇,张卓奇,王克明.背阔肌肌皮瓣乳房再造术后腋前皱襞的重建[J].中国美容医学,2007,16(3):319-321. 被引量:21
  • 4Ahmedin J D, Rebecca S, Elizabeth W, et al. Cancer Statis- tics [J]. Cancer J Clin, 2008, 58(2): 71.
  • 5Femandez- Delgado J, Lopez- Pedraza M J, Blasco J A, et al. Satisfaction with and psychological impact of immediate and deferred breast reconstruction[J]. Ann Oncol, 2008, 19 (8) : 1430.
  • 6Agaoglu G, Erol O O. Delayed breast reconstruction with latissimus dorsi flap[J]. Adsthetie Plast Surg, 2009, 33(3) : 413.
  • 7Elisabetta Bandiera, Chiara Romani, Claudia Specchia, et aL Serum human epididymis protein 4 (HE4) and Risk for Ovar- ian Malignancy Algorithm (ROMA) as new diagnostic and prognostic tools for epithelial ovarian cancer management[J]. Cancer Epidemiol Biomarkers Prey, 2011, 20(12) : 2496.
  • 8Nirmal Chhikara, Mayank Saraswat, Anil Kumar Tomar, et al. Human Epididymis Protein-4 ( HE-4 ) : A Nove[ CroKs- Class Protease Inhibitor [J]. PLoS One, 2012, 7 ( 11 ) :47672.
  • 9Yuanzhu Jiang, Chao Wang, Baoyu Lv, et al. Expression level of serum human epididymis 4 and its prognostic signifi- cance in human non-small cell lung cancer[J ]. Int J Clin Exp Med, 2014, 7(12): 5568.
  • 10Emanuela Anastasi, Teresa Granato, Renato Falzarano, et al. The use of HE4, CA125 and CA72-4 biomarkers for dif- ferential diagnosis between ovarian endometrioma and epithe- lial ovarian cancer[J]. J Ovarian Res, 2013, 5(4): 78.

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部